UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

6ER-001 Association between faecal calprotectin values and infliximab trough levels in inflammatory bowel disease patients

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A229-A231

2018

Volltextzugriff (PDF)

6ER-001 Can pharmacists improve their patient communication by reading fiction? Narrative medicine in pharmacy practice – a feasibility study

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A168-A168

2022

Volltextzugriff (PDF)

6ER-001 The use of gamification to evaluate public understanding of adverse drug reactions

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A161-A161

Lin, YN

2023

Volltextzugriff (PDF)

6ER-002 Applying reflective multicriteria decision analysis to understand the value of therapeutic alternatives in the management of anaemia in gynaecologic surgery

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A168-A169

2022

Volltextzugriff (PDF)

6ER-002 Assessement of efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors (i-pcsk9) for hypercholesterolaemia with or without statins

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A230-A230

2018

Volltextzugriff (PDF)

6ER-003 Blind comparative study in telangiectasias and reticular veins treatment with nd:yag laser and sclerotherapy

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A230-A230

2018

Volltextzugriff (PDF)

6ER-004 Comparative study between intense pulsed light combined with vacuum and pils versus pils in endocrine acne in females

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A231-A231

2018

Volltextzugriff (PDF)

6ER-004 Effectiveness and safety of COVID-19 vaccination in patients with immune-mediated diseases on biological therapy

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A161-A161

2023

Volltextzugriff (PDF)

6ER-005 Comprehensive programme for prevention and control of infections related to health care and appropriate use of antimicrobials: one more step

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A231-A232

2018

Volltextzugriff (PDF)

6ER-005 Effects of adherence to the Mediterranean diet in patients with autoimmune diseases

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A161-A162

2023

Volltextzugriff (PDF)

6ER-005 Reducing invasive device-related bloodstream infections: a challenge for the prevention of healthcare-associated infections

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A169-A169

2022

Volltextzugriff (PDF)

6ER-006 Use of piperacillin-tazobactam in a university hospital

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A232-A232

2018

Volltextzugriff (PDF)

6ER-007 Impact of optimising use of carbapenem antibiotics programme

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A232-A234

2018

Volltextzugriff (PDF)

6ER-008 Correlates of one-year mortality among patients living with HIV according to the stratification level of the pharmaceutical care model

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A162-A162

2023

Volltextzugriff (PDF)

6ER-008 Evaluation of patient, virus and treatment baseline factors affecting the effectiveness of direct antiviral agents against the hepatitis c virus

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A233-A233

2018

Volltextzugriff (PDF)

6ER-009 Can tolerability and safety of daa-2 for hepatitis c be estimated only by randomised clinical trials? a systematic review with meta-analysis

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A233-A233

2018

Volltextzugriff (PDF)

6ER-009 Comparative efficacy of abemaciclib and palbociclib as adjuvant treatment in patients with early breast cancer

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A162-A163

2023

Volltextzugriff (PDF)

6ER-010 Evolution of onco-haematological clinical trials from 2016 to 2021: experience from a tertiary hospital

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A163-A163

2023

Volltextzugriff (PDF)

6ER-010 Focus on hcv treatment based on second-generation direct-acting antiviral agents (daas-2): comparing national and local prescribing trends

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A234-A234

2018

Volltextzugriff (PDF)

6ER-011 Drug utilisation study of bevacizumab in a teaching referral paediatric hospital

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A234-A234

2018

Volltextzugriff (PDF)

6ER-011 Efficacy of therapies in non-small-cell lung cancer with eGFR exon 20 insertion mutations: a systematic review

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A163-A164

2023

Volltextzugriff (PDF)

6ER-012 Effectiveness of IL-23 inhibitors in patients with moderate–severe chronic plaque psoriasis

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A171-A171

2022

Volltextzugriff (PDF)

6ER-012 Withdrawn

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A235-A235

2018

Volltextzugriff (PDF)

6ER-013 Analysis of biological treatments as possible therapeutic alternatives in refractory anti-tnf patients in crohn’s disease

European journal of hospital pharmacy. Science and practice, 2018-03, Vol.25 (Suppl 1), p.A235-A237

2018

Volltextzugriff (PDF)

6ER-014 Analysis of the evolution of interleukin-6 in COVID-19 patients after being treated with dexamethasone

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A171-A172

2022

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(83)

Sprache

Englisch
(83)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

6ER-001 Association between faecal calprotectin values and infliximab trough levels in inflammatory bowel disease patients

6ER-001 Can pharmacists improve their patient communication by reading fiction? Narrative medicine in pharmacy practice – a feasibility study

6ER-001 The use of gamification to evaluate public understanding of adverse drug reactions

6ER-002 Applying reflective multicriteria decision analysis to understand the value of therapeutic alternatives in the management of anaemia in gynaecologic surgery

6ER-002 Assessement of efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors (i-pcsk9) for hypercholesterolaemia with or without statins

6ER-003 Blind comparative study in telangiectasias and reticular veins treatment with nd:yag laser and sclerotherapy

6ER-004 Comparative study between intense pulsed light combined with vacuum and pils versus pils in endocrine acne in females

6ER-004 Effectiveness and safety of COVID-19 vaccination in patients with immune-mediated diseases on biological therapy

6ER-005 Comprehensive programme for prevention and control of infections related to health care and appropriate use of antimicrobials: one more step

6ER-005 Effects of adherence to the Mediterranean diet in patients with autoimmune diseases

6ER-005 Reducing invasive device-related bloodstream infections: a challenge for the prevention of healthcare-associated infections

6ER-006 Use of piperacillin-tazobactam in a university hospital

6ER-007 Impact of optimising use of carbapenem antibiotics programme

6ER-008 Correlates of one-year mortality among patients living with HIV according to the stratification level of the pharmaceutical care model

6ER-008 Evaluation of patient, virus and treatment baseline factors affecting the effectiveness of direct antiviral agents against the hepatitis c virus

6ER-009 Can tolerability and safety of daa-2 for hepatitis c be estimated only by randomised clinical trials? a systematic review with meta-analysis

6ER-009 Comparative efficacy of abemaciclib and palbociclib as adjuvant treatment in patients with early breast cancer

6ER-010 Evolution of onco-haematological clinical trials from 2016 to 2021: experience from a tertiary hospital

6ER-010 Focus on hcv treatment based on second-generation direct-acting antiviral agents (daas-2): comparing national and local prescribing trends

6ER-011 Drug utilisation study of bevacizumab in a teaching referral paediatric hospital

6ER-011 Efficacy of therapies in non-small-cell lung cancer with eGFR exon 20 insertion mutations: a systematic review

6ER-012 Effectiveness of IL-23 inhibitors in patients with moderate–severe chronic plaque psoriasis

6ER-012 Withdrawn

6ER-013 Analysis of biological treatments as possible therapeutic alternatives in refractory anti-tnf patients in crohn’s disease

6ER-014 Analysis of the evolution of interleukin-6 in COVID-19 patients after being treated with dexamethasone

Suchergebnisse filtern